Mario Gabelli Chroma Dex Corp. Transaction History
Gamco Investors, Inc. Et Al
- $8.56 Billion
- Q2 2024
A detailed history of Mario Gabelli (Gamco Investors, Inc. Et Al) transactions in Chroma Dex Corp. stock. As of the latest transaction made, Gamco Investors, Inc. Et Al holds 233,150 shares of CDXC stock, worth $885,970. This represents 0.01% of its overall portfolio holdings.
Number of Shares
233,150
Previous 263,850
11.64%
Holding current value
$885,970
Previous $918,000
30.72%
% of portfolio
0.01%
Previous 0.01%
Shares
5 transactions
Others Institutions Holding CDXC
# of Institutions
82Shares Held
16.4MCall Options Held
91.7KPut Options Held
18.9K-
Vanguard Group Inc Valley Forge, PA3.39MShares$12.9 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.12MShares$11.8 Million0.0% of portfolio
-
Tieton Capital Management, LLC Yakima, WA2.97MShares$11.3 Million4.5% of portfolio
-
Iconiq Capital, LLC San Francisco, CA1.3MShares$4.93 Million0.07% of portfolio
-
Geode Capital Management, LLC Boston, MA1.13MShares$4.3 Million0.0% of portfolio
About ChromaDex Corp.
- Ticker CDXC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 68,350,896
- Market Cap $260M
- Description
- ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingre...